Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma
Jacob L Goldberg, Fariba Navid, Jacquelyn A Hank, Amy K Erbe, Victor Santana, Jacek Gan, Fenna de Bie, Amal M Javaid, Anna Hoefges, Michael Merdler, Lakeesha Carmichael, KyungMann Kim, Michael W Bishop, Michael M Meager, Stephen D Gillies, Janardan P Pandey, Paul M Sondel
Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000590; DOI: 10.1136/jitc-2020-000590
